Nektar(NKTR) - 2023 Q2 - Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Vivian Wu - Director, Investor Relations and Corporate Affairs Howard Robin - President and CEO Dr. Jonathan Zalevsky - Chief, Research and Development Dr. Mary Tagliaferri - Chief Medical Officer Jennifer Ruddock - Chief Business Officer Sandra Gardiner - Acting Chief Financial Officer Conference Call Participants Cheng Li - Oppenheimer & Co. Inc. Mara Goldstein - Mizuho Kambiz Yazdi - Jefferie ...